世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033524

世界の非動物代替試験の市場規模調査:技術別、方法別、エンドユーザー別、地域別の分析(2022年〜2028年)

Bizwit Research & Consulting LLP

Global Non-Animal Alternative Testing Market Size study, By Technology (Cell Culture, High Throughput, Molecular Imaging, OMIC Technology) By Method (Cellular Assay, Biochemical Assay, In-silico, Ex-vivo), End User (Pharmaceutical Industry, Cosmetics & Household Products, Diagnostics, Chemicals Industry, Food Industry) and Regional Forecasts 2022-2028

発刊日 2022/09/29

言語英語

体裁PDF/200ページ

ライセンス/価格200ページ

0000033524

Single
Enterprise (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

世界の非動物代替試験市場は、2021年に約98億米ドルと評価され、予測期間の2022年から2028年には13.50%を超える健全な成長率で成長すると予測されています。

非動物代替試験とは、医薬品や化粧品などの製品の安全性要件を確立するために、動物を利用しない試験方法です。医薬品や化粧品は、非動物代替物を用いて試験されますが、利用される方法論には、器官オンチップ、インビトロ試験、インシリコ試験などがあります。慢性疾患の有病率の上昇、臓器オンチップ技術の利用の増加、主要な市場プレイヤーの戦略的イニシアチブは、市場の成長を加速させる主要因となっています。National Health Council USAによると、2020年現在、約4,000万人のアメリカ国民が1つ以上の慢性的な健康状態により、通常の活動に制限を受けています。また、約1億3,300万人のアメリカ市民が慢性疾患の影響を受けており、これは同国の総人口の40%以上に相当します。さらに、世界中の当局が非動物実験法を承認しており、この要因は予測期間中の市場の成長に影響を与えるでしょう。例えば、2021年に経済協力開発機構は、動物実験を適用せずに皮膚アレルギー反応を予測するための最初の全体的な試験戦略を承認しました。また、医薬品試験における動物の使用を禁止するための当局からの有利なイニシアチブの増加や、体外試験における進歩の増加は、予測期間中に市場のための有利な機会を創出するでしょう。しかし、認知度の低さが2022年から2028年の予測期間における市場の成長を阻害するでしょう。

世界の非動物代替試験市場の調査において考慮された主要地域は、アジア太平洋、北アメリカ、ヨーロッパ、ラテンアメリカ、世界のその他の地域です。北アメリカは、慢性疾患の発生率の上昇や、同地域における主要な市場プレイヤーの存在などの要因から、主要地域となっています。一方、アジア太平洋地域は、前臨床試験における動物の使用が禁止されつつあることから、最も急速に成長する地域と予想されています。また、現在、新興国市場の大手企業は、同地域の新製品導入に投資し、研究施設や活動の発展を支援しています。今後数年間は、これらの要因が非動物代替試験市場の拡大を促進すると予測されます。

主要企業

  • VITROCELL Systems GmbH
  • Evotec SE
  • Biovit
  • MB Research Laboratories
  • Emulate, Inc.
  • TARA Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • Abbott
  • Hurel Corporation
  • TissUse GmbH

本調査の目的は、近年における様々なセグメント・国の市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

さらに、市場の今後の成長を決定づける推進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競争環境と製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

市場セグメント・サブセグメント

  • 技術別
    ➣ 細胞培養
    ➣ ハイスループット
    ➣ モレキュラーイメージング
    ➣ OMIC技術
  • 方法別
    ➣ 細胞培養アッセイ
    ➣ 生化学的アッセイ
    ➣ インシリコ
    ➣ エクスビボ
  • エンドユーザー別
    ➣ 製薬業界
    ➣ 化粧品・日用品
    ➣ 診断薬
    ➣ 化学工業
    ➣ 食品産業
  • 地域別
    ➣ 北アメリカ
      ◇ アメリカ
      ◇ カナダ
    ➣ ヨーロッパ
      ◇ イギリス
      ◇ ドイツ
      ◇ フランス
      ◇ スペイン
      ◇ イタリア
      ◇ その他のヨーロッパ
    ➣ アジア太平洋地域
      ◇ 中国
      ◇ インド
      ◇ 日本
      ◇ オーストラリア
      ◇ 韓国
      ◇ その他のAPAC
    ➣ ラテンアメリカ
      ◇ ブラジル
      ◇ メキシコ
    ➣ 世界のその他の地域

調査対象年

  • 実績データ - 2018年、2019年、2020年
  • 基準年 - 2021年
  • 予測期間 - 2022年から2028年

レポート詳細

目次

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Non-Animal Alternative Testing Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Non-Animal Alternative Testing Market, by Technology, 2020-2028 (USD Billion)
1.2.3. Global Non-Animal Alternative Testing Market, by Method, 2020-2028 (USD Billion)
1.2.4. Global Non-Animal Alternative Testing Market, by End User, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Non-Animal Alternative Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Non-Animal Alternative Testing Market Dynamics
3.1. Non-Animal Alternative Testing Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of chronic diseases
3.1.1.2. Increase in usage of organs-on-chip technology.
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. Legal requirement for animal testing in some countries.
3.1.3. Market Opportunities
3.1.3.1. Favourable initiatives from authorities to ban the usage of animals in drug testing
3.1.3.2. Growing advancements in In-vitro testing.

Chapter 4. Global Non-Animal Alternative Testing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Non-Animal Alternative Testing Market, by Technology
6.1. Market Snapshot
6.2. Global Non-Animal Alternative Testing Market by Technology, Performance - Potential Analysis
6.3. Global Non-Animal Alternative Testing Market Estimates & Forecasts by Technology 2018-2028 (USD Billion)
6.4. Non-Animal Alternative Testing Market, Sub Segment Analysis
6.4.1. Cell Culture
6.4.2. High Throughput
6.4.3. Molecular Imaging
6.4.4. OMIC Technology

Chapter 7. Global Non-Animal Alternative Testing Market, by Method
7.1. Market Snapshot
7.2. Global Non-Animal Alternative Testing Market by Method, Performance - Potential Analysis
7.3. Global Non-Animal Alternative Testing Market Estimates & Forecasts by Method 2018-2028 (USD Billion)
7.4. Non-Animal Alternative Testing Market, Sub Segment Analysis
7.4.1. Cellular Assay
7.4.2. Biochemical Assay
7.4.3. In-silico
7.4.4. Ex-vivo

Chapter 8. Global Non-Animal Alternative Testing Market, by End User
8.1. Market Snapshot
8.2. Global Non-Animal Alternative Testing Market by End User, Performance - Potential Analysis
8.3. Global Non-Animal Alternative Testing Market Estimates & Forecasts by End User 2018-2028 (USD Billion)
8.4. Non-Animal Alternative Testing Market, Sub Segment Analysis
8.4.1. Pharmaceutical Industry
8.4.2. Cosmetics & Household Products
8.4.3. Diagnostics
8.4.4. Chemicals Industry
8.4.5. Food Industry

Chapter 9. Global Non-Animal Alternative Testing Market, Regional Analysis
9.1. Non-Animal Alternative Testing Market, Regional Market Snapshot
9.2. North America Non-Animal Alternative Testing Market
9.2.1. U.S. Non-Animal Alternative Testing Market
9.2.1.1. Technology estimates & forecasts, 2018-2028
9.2.1.2. Method estimates & forecasts, 2018-2028
9.2.1.3. End User estimates & forecasts, 2018-2028
9.2.2. Canada Non-Animal Alternative Testing Market
9.3. Europe Non-Animal Alternative Testing Market Snapshot
9.3.1. U.K. Non-Animal Alternative Testing Market
9.3.2. Germany Non-Animal Alternative Testing Market
9.3.3. France Non-Animal Alternative Testing Market
9.3.4. Spain Non-Animal Alternative Testing Market
9.3.5. Italy Non-Animal Alternative Testing Market
9.3.6. Rest of Europe Non-Animal Alternative Testing Market
9.4. Asia-Pacific Non-Animal Alternative Testing Market Snapshot
9.4.1. China Non-Animal Alternative Testing Market
9.4.2. India Non-Animal Alternative Testing Market
9.4.3. Japan Non-Animal Alternative Testing Market
9.4.4. Australia Non-Animal Alternative Testing Market
9.4.5. South Korea Non-Animal Alternative Testing Market
9.4.6. Rest of Asia Pacific Non-Animal Alternative Testing Market
9.5. Latin America Non-Animal Alternative Testing Market Snapshot
9.5.1. Brazil Non-Animal Alternative Testing Market
9.5.2. Mexico Non-Animal Alternative Testing Market
9.6. Rest of The World Non-Animal Alternative Testing Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. VITROCELL Systems GmbH
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Evotec SE
10.2.3. Biovit
10.2.4. MB Research Laboratories
10.2.5. Emulate, Inc.
10.2.6. TARA Biosystems, Inc.
10.2.7. Bio-Rad Laboratories, Inc.
10.2.8. Abbott
10.2.9. Hurel Corporation
10.2.10. TissUse GmbH

Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

LIST OF TABLES
TABLE 1. Global Non-Animal Alternative Testing Market, report scope
TABLE 2. Global Non-Animal Alternative Testing Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Non-Animal Alternative Testing Market estimates & forecasts by Technology 2018-2028 (USD Billion)
TABLE 4. Global Non-Animal Alternative Testing Market estimates & forecasts by Method 2018-2028 (USD Billion)
TABLE 5. Global Non-Animal Alternative Testing Market estimates & forecasts by End User 2018-2028 (USD Billion)
TABLE 6. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Non-Animal Alternative Testing Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Non-Animal Alternative Testing Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Non-Animal Alternative Testing Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Non-Animal Alternative Testing Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Non-Animal Alternative Testing Market
TABLE 56. List of primary sources, used in the study of global Non-Animal Alternative Testing Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered

LIST OF FIGURES
FIG 1. Global Non-Animal Alternative Testing Market, research methodology
FIG 2. Global Non-Animal Alternative Testing Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Non-Animal Alternative Testing Market, key trends 2021
FIG 5. Global Non-Animal Alternative Testing Market, growth prospects 2022-2028
FIG 6. Global Non-Animal Alternative Testing Market, porters 5 force model
FIG 7. Global Non-Animal Alternative Testing Market, pest analysis
FIG 8. Global Non-Animal Alternative Testing Market, value chain analysis
FIG 9. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Non-Animal Alternative Testing Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Non-Animal Alternative Testing Market, regional snapshot 2018 & 2028
FIG 15. North America Non-Animal Alternative Testing Market 2018 & 2028 (USD Billion)
FIG 16. Europe Non-Animal Alternative Testing Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific market 2018 & 2028 (USD Billion)
FIG 18. Latin America Non-Animal Alternative Testing Market 2018 & 2028 (USD Billion)
FIG 19. Global Non-Animal Alternative Testing Market, company market share analysis (2021)

この商品のレポートナンバー

0000033524

TOP